Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients

NCT01446185 is registered in ClinicalTrials.gov with Genomic Health®, Inc. as lead sponsor.

NCT NCT01446185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01446185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients
Lead sponsor
Genomic Health®, Inc.
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2011
Completion date
May 31, 2012
Enrollment
100 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer